Literature DB >> 27660408

Patients' tolerance of bimanual lid retraction versus a metal speculum for intravitreal injections.

Khadijah Alattas1.   

Abstract

OBJECTIVE: To compare patients' acceptance of and correlate their pain level for bimanual versus metal speculum fixation in intravitreal injections.
DESIGN: Prospective analysis. PARTICIPANTS: Seventy-three eyes of 56 patients.
METHODS: A questionnaire indicating patients' discomfort and pain grading immediately after intravitreal injections using either bimanual fixation or metal speculum fixation (Barraquer Wire Speculum).
RESULTS: Fifty-six patients who underwent intravitreal injections were enrolled in this study for various conditions. Patients' overall pain and discomfort were as follows, right eye - bimanual was 0.3 on our grading scale with a standard deviation of 0.54, right eye - metal was 1.6 on our grading scale with a standard deviation of 1.5, left eye - bimanual was 0.41 on our grading scale with a standard deviation of 0.87, and left eye - metal was 1.91 on our grading scale with a standard deviation of 1.14 (P=0.003).
CONCLUSION: Patients who underwent bimanual fixation had a much more comfortable experience with less pain in comparison to patients who underwent metal speculum fixation.

Entities:  

Keywords:  AMD; Avastin; diabetic retionpathy; eye injection

Year:  2016        PMID: 27660408      PMCID: PMC5019478          DOI: 10.2147/OPTH.S113326

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

As ophthalmic care has been progressing in recent years with the breakthrough of intravitreal injections, and as more and more patients are having that procedure and causing an increase in the number of these procedures, ensuring the patient has the best possible experience with minimal pain and discomfort has become essential. Finemen et al’s1 study emerged comparing patientspain and discomfort threshold correlated with their eye fixation method – bimanual fixation or metal fixation, here we discuss patients’ reactions comparing these two entities together. The speculum has the advantage of freeing the physician’s hands and is able to function in a better, wider field, while keeping the eyelids and possible pathogens away from the injection site, using a modified grading scale from Rahimy et al’s2 study, as Tailor et al3 found that a metal speculum can lead to patient discomfort.

Methods

A single center prospective questionnaire grading the patients’ discomfort and pain levels in a step-wise approach to the procedure, ranging from eyelid retraction to the end of the intravitreal injection procedure was employed. Approval from King Abdulaziz Univeristy Hospital ethics board was obtained for this study. All participants provided written informed consent to be included in the study. Seventy-three eyes of 56 patients were enrolled in this study, 46 patients underwent injections to their right eye, of these 12 had metal fixation and 34 had bimanual fixation; 27 patients underwent injections to their left eye, of these 12 were metal 15 and were bimanual fixation. Seventeen patients underwent injections in both eyes on the same day using different methods for both eyes, one eye being bimanual versus the other being metal, grading was done for each step of the procedure with a grading scale from 0 to 5 with 0 correlating to no pain or discomfort and 5 correlating to the maximum quantity of pain or discomfort as experienced by the patient. The next steps involved eyelid retraction, instillation of povidone iodine 5%, topical anesthesia application, intravitreal injection, and grading of overall pain and discomfort.

Results

Our results showed a great majority of patients preferred the bimanual technique (75.4%) in comparison to the metal speculum (15%) with the remainder having no particular favorite. Of the patients, 86.2% had undergone a previous injection, 87.9% of the patients were injected for diabetic macular edema. The overall pain scale is shown in Table 1, metal speculum eyelid retraction in the right eye scored a low pain score but scored zero in the bimanually fixated eye with a P-value of less than 0.003, povidone iodine 5% and anesthesia application were comparable in both eyes, intravitreal injection showed a significant P-value with a lower pain score in the bimanually fixated eye (0.94±0.84) compared to the metal speculum fixated eye (1.6±1.5) with a P-value less than 0.001.
Table 1

Overall pain scale results

VariablesMean ± SD(Min–Max)
Pain eyelid retraction OD0.21±0.8(0–5)
Pain povidone iodine OD0.40±0.6(0–2)
Anesthesia application OD0.11±0.3(0–1)
Intravitreal injection OD1.4±1.2(0–5)
Overall OD0.64±1.0(0–5)
Pain eyelid retraction OS0.45±0.9(0–3)
Pain povidone iodine OS0.45±0.6(0–2)
Anesthesia application OS0.10±0.3(0–1)
Intravitreal injection OS1.1±1.0(0–3)
Overall OS1.0±1.2(0–4)

Note: Grading scale from 0 to 5 with 0 correlating to no pain or discomfort and 5 correlating to the maximum quantity of pain or discomfort, as presumed by the patient.

Abbreviations: Max, maximum; min, minimum; OD, right eye; OS, left eye; SD, standard deviation.

Metal speculum eyelid retraction in the left eye scored a low pain score, but the pain score was even less in the bimanually fixated eye with a P-value of less than 0.04; povidone iodine 5% and anesthesia application were comparable in both eyes, intravitreal injection showed a significant P-value with a lower pain score in the bimanually fixated eye (0.53±0.62) compared to the metal speculum fixated eye (1.91±1.14) with a P-value less than 0.001 being statistically significant; for detailed description see Tables 2 and 3.
Table 2

Right eye pain score results

VariablesRight eye (OD) pain score
P-value
Bimanual fixationMetal speculum fixation
Pain eyelid retraction00±0.000.83±1.50.003**
Pain povidone iodine0.38±0.610.42±0.520.84
Anesthesia application0.06±0.250.25±0.450.08
Intravitreal injection0.94±0.842.6±1.20.001***
Overall0.31±0.541.6±1.50.001***

Notes: Data shown as mean ± SD or P-value.

Significant P-value less than 0.01;

extremely significant P-value less than 0.001. Grading scale from 0 to 5 with 0 correlating to no pain or discomfort and 5 correlating to the maximum quantity of pain or discomfort, as presumed by the patient.

Table 3

Left eye pain score results

VariablesLeft eye (OS) pain score
P-value
Bimanual fixationMetal speculum fixation
Pain eyelid retraction OS0.18±0.390.83±1.20.004**
Pain povidone iodine OS0.47±0.720.42±0.520.83
Anesthesia application OS0.06±0.240.17±0.390.37
Intravitreal injection OS0.53±0.621.92±0.990.001***
Overall OS0.41±0.871.91±1.140.001***

Notes: Data shown as mean ± SD or P-value.

Significant P-value less than 0.01;

extremely significant P-value less than 0.001. Grading scale from 0 to 5 with 0 correlating to no pain or discomfort and 5 correlating to the maximum quantity of pain or discomfort, as presumed by the patient.

Conclusion

Patients preferred injections using the bimanual fixation method much more than the metal speculum method, a larger study sample is needed in future studies, although according to our study it appears to be statistically significant.
  3 in total

1.  Speculum versus Bimanual Lid Retraction during Intravitreal Injection.

Authors:  Ehsan Rahimy; Mitchell S Fineman; Carl D Regillo; Marc J Spirn; Jason Hsu; Richard S Kaiser; Joseph I Maguire; Gary C Brown; Allen Chiang
Journal:  Ophthalmology       Date:  2015-02-26       Impact factor: 12.079

2.  Bimanual assisted eyelid retraction technique for intravitreal injections.

Authors:  Mitchell S Fineman; Jason Hsu; Marc J Spirn; Richard S Kaiser
Journal:  Retina       Date:  2013-10       Impact factor: 4.256

3.  Evaluation of patients' experiences at different stages of the intravitreal injection procedure - what can be improved?

Authors:  Rajen Tailor; Rebecca Beasley; Yit Yang; Niro Narendran
Journal:  Clin Ophthalmol       Date:  2011-10-14
  3 in total
  1 in total

1.  Comparison of Two Different Intravitreal Injection Techniques.

Authors:  Harvey S Uy; Jose Carlo M Artiaga
Journal:  Clin Ophthalmol       Date:  2021-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.